It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.